Inhalation carcinogenicity study with nickel metal powder in Wistar rats

Toxicology and Applied Pharmacology

Volumn 233, Issue 2, 2008, Pages 262-275

  Oller, Adriana R ^a   Kirkpatrick, Daniel T ^b   Radovsky, Ann ^b   Bates, Hudson K ^a  

^a NiPERA   (United States)

^b WIL RESEARCH LABORATORIES   (United States)

Author keywords

Cancer; Carcinogenicity; Inhalation; Metal; Nickel

Indexed keywords

METAL; NICKEL;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLAR ALVEOLAR HYPERPLASIA; CARCINOGENICITY; CHRONIC INFLAMMATION; CONTROLLED STUDY; EXPOSURE; FEMALE; HISTIOCYTOSIS; HYPERPLASIA; INCIDENCE; INHALATION; LUNG ALVEOLUS PROTEINOSIS; LUNG TOXICITY; MALE; MORTALITY; NONHUMAN; PHEOCHROMOCYTOMA; POWDER; RAT;

ADRENAL CORTEX NEOPLASMS; ADRENAL GLAND NEOPLASMS; ADRENOCORTICAL ADENOMA; ADRENOCORTICAL CARCINOMA; ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INHALATION EXPOSURE; LUNG; MALE; MODELS, ANIMAL; NICKEL; OCCUPATIONAL EXPOSURE; PHEOCHROMOCYTOMA; POWDERS; RATS; RATS, WISTAR; RESPIRATORY TRACT NEOPLASMS; SEX FACTORS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 56049097874     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.08.017     Document Type: Article

References (62)

1. Abbracchio, M.P., Simmons-Hansen, J., Costa, and M. Cytoplasmic dissolution of phagocyized crystalline nickel sulfide particles: a prerequisite for nuclear uptake of nickel. J. Toxicol. Environ. Health 9 (1982) 663-676
2. ACGIH, 1998. American Conference of Governmental Industrial Hygienists: threshold limit values and biological exposure indices for chemical substances and physical agents. Cincinnati, OH, p.51.
3. Andersen A., Berge S.R., Engeland A., and Norseth T. Exposure to nickel compounds and smoking in relation to incidence of lung and nasal cancer among nickel refinery workers. Occup. Environ. Med. 53 (1996) 708-713
4. ATSDR (Agency for Toxic Substances and Disease Registry). Toxicological Profile for Nickel. U.S. Department of Health and Human Services, Atlanta, Georgia. PB2006-100005 (2005)
5. Bomhard E. Frequency of spontaneous tumors in Wistar rats in 30-months studies. Exp. Toxicol. Pathol. 44 (1992) 381-392
6. Boorman G.A., and Eustis S.L. The lung. Pathology of the Fischer Rat (1990), Academic Press, San Diego 348
7. Boorman G.A., Brockmann M., Carlton W.W., Davis J.M., Dungworth D.L., Hahn F.F., Mohr U., Reichhelm H.B., Turusov V.S., and Wagner B.M. Classification of cystic keratinizing squamous lesions of the rat lung: report of a workshop. Toxicol. Pathol. 24 5 (1996) 564-572 Sep-Oct
8. Benson J.M., Barr E.B., Bechtold W.E., Cheng Y.S., Dunnick J.K., Eastin W.E., Hobbs C.H., Kennedy C.H., and Maples K.R. Fate of inhaled nickel oxide and nickel subsulfide in F344/N rats. Inhal. Toxicol. 6 (1994) 167-183
9. Benson J.M., Chang I.-Y., Cheng Y.S., Hahn F.F., Kennedy C.H., Barr E.B., Maples K.R., and Snipes M.B. Particle clearance and histopathology in lungs of F344/N rats and B6C3F1 mice inhaling nickel oxide or nickel sulfate. Fundam. Appl. Toxicol. 28 (1995) 232-244
10. Bunn H.F., Gu J., Huang E., Park J.-W., and Zhu H. Erythropoietin: a model system for studying oxygen-dependent gene regulation. J. Exp. Biol. 201 (1998) 1197-1201
11. Costa M., and Mollenhauer H.H. Phagocytosis of nickel subsulfide particles during the early stages of neoplastic transformation in tissue culture. Cancer Res. 40 (1980) 2688-2694
12. Costa M., Yan Y., Zhao D., and Salnikow K. Molecular mechanisms of nickel carcinogenesis: gene silencing by nickel delivery to the nucleus and gene activation/inactivation by nickel-induced cell signaling. J Environ Monit. 5 2 (2003) 222-223 2003 Apr, Review
13. Costa M., Davidson T.L., Chen H., Ke Q., Zhang P., Yan Y., Huang C., and Kluz T. Nickel carcinogenesis: epigenetics and hypoxia signaling. Mutat Res. 30 592(1-2) (2005) 79-88
14. Driscoll K.E., Costa D.L., Hatch G., Henderson R., Oberdörster G., Salem H., and Schlesinger R.B. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol. Sciences 55 (2000) 24-35
15. Dunnett C.W. New tables for multiple comparisons with a control. Biometrics 20 (1964) 482-491
16. European Union Existing Substances Risk Assessment Report for Nickel Metal (May 2006, Chapter 4: Human Health). Danish Environmental Protection Agency. http://ecb.jrc.it/documents/Existing-Chemicals/RISK_ASSESSMENT/EURATS/RAR_STATUS/eurats_MS_311.pdf.
17. EPA 1986. Health assessment document for nickel and nickel compounds (Final Report, September 1986. Pages 8-113.
18. Gehan E.A. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika, 52 (1965) 203-223
19. Grimsrud T.K., Berge S.R., Haldorsen T., and Andersen A. Exposure to different forms of nickel and risk of lung cancer. Am. J. Epidemiol. 156 (2002) 1123-1132
20. Haseman J.K. A reexamination of false-positive rates for carcinogenesis studies. Fundam. Appl. Toxicol. 3 (1983) 334-339
21. Haseman J.K., Hailey J.R., and Morris R.W. Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program update. Toxicol. Pathol. 26 (1998) 428-441
22. Hayman P.B., Goodgame D.M.L., and Snook R.D. Studies of nickel absorption in rats using inductively coupled plasma atomic-emission spectrometry and liquid scintillation counting. Analyst 109 (1984) 1593-1595
23. Heim K.E., Bates H.K., Rush R.E., and Oller A.R. Oral carcinogenicity study with nickel sulfate hexahydrate in Fischer 344 rats. Fundam. Appl. Toxicol. 224 (2007) 126-137
24. Hueper W.C. Experimental studies in metal carcinogenesis: IX. Pulmonary lesions in guinea pigs and rats exposed to prolonged inhalation of powdered metallic nickel. AMA Arch. Pathol. 65 (1958) 600-607
25. Hueper W.C., and Payne W.W. Experimental studies in metal carcinogenesis. Arch. Environ. Health 5 (1962) 445-462
26. IARC. International agency for research on cancer and World Health Organization monographs on the evaluation of carcinogenic risks to humans: chromium, nickel and welding. International Agency for Research on Cancer 49 (1990), Lyon, France 90 677
27. ICNCM. International committee on nickel carcinogenesis in man. Report of the International Committee on Nickel Carcinogenesis in Man (1990) 1-82
28. Ishimatsu S., Kawamoto T., Matsuno K., and Kodama Y. Distribution of various nickel compounds in rat organs after oral administration. Biol. Trace Elem. Res. 49 1 (1995) 43-52
29. Ivankovic S., Zeller W.J., Komitowski D., Edler L., Lehman E., and Frohlich N. Carcinogenesis of nickel alloys in the hamster following intratracheal instillation. Schriftenreihe der Bundesanstalt für Arbeitsschutz, Dortmund (1988) 1-58
30. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53 (1958) 457-481
31. Ke Q., Davidson T., Kluz T., Oller A., and Costa M. Fluorescent tracking of nickel ions in human cultured cells. Toxicol. Appl. Pharmacol. 219 1 (2007) 18-23 Electronic publication 2006 Oct 28
32. Kirkpatrick D.T. A 13-week inhalation toxicity study (with recovery) of nickel metal in albino rats (Study No. WIL-437002). WIL Research Laboratories, Inc., Ashland, Ohio, 2004 (2004)
33. Kirkpatrick D.T. A 24-months inhalation carcinogenicity study of nickel metal (with a six-months senescence period) in Wistar rats (Study No. WIL-437003). WIL Research Laboratories, Inc., Ashland, Ohio, April, 2008 (2008)
34. Lin K.K. A regulatory perspective on statistical methods for analyzing new drug carcinogenicity study data. Bio/Pharam. Q. 1 2 (1995) 18-20
35. Lin, K.K., 1997. Control of Overall False Positive Rates in Animal Carcinogenicity Studies of Pharmaceuticals, presented at the FDA Forum on Regulatory Science, Bethesda, MD, December 8-9, 1997.
36. Lin K.K., and Rahman M.A. Overall false positive rates in tests for linear trend in tumor incidence in animal carcinogenicity studies of new drugs. J. Pharm. Stat. 8 1 (1988) 1-22
37. Lin K.K., and Rahman M.A. False positive rates in tests for trend and differences in tumor incidence in animal carcinogenicity studies of pharmaceuticals under ICH guidance SIB, unpublished report. Division of Biometrics 2, Center for Drug Evaluation and Research, Food and Drug Administration (1988)
38. Lin X., and Costa M. Transformation of human osteoblasts to anchorage-independent growth by insoluble nickel particles. Environ. Health Perspect. 102 Suppl 3 (1994) 289-292 Sep
39. Maxwell P., and Salnikow K. HIF-1: an oxygen and metal responsive transcription factor. Cancer Biol. Ther. 3 1 (2004) 29-35 2004 Jan, Electronic publication 2004 Jan 10. Review
40. McConnell E.E., Solleveld H.A., Swenberg J.A., and Boorman G.A. Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. J. Natl. Cancer Inst. 76 (1986) 283-289
41. Miura T., Patierno S.R., Sakuramoto T., and Landolph J.R. Morphological and neoplastic transformation of C3H/10T1/2 Cl 8 mouse embryo cells by insoluble carcinogenic nickel compounds. Environ. Mol. Mutagen. 14 2 (1989) 65-78
42. Muhle H., Bellmann B., Takenaka S., Fuhst R., Mohr U., and Pott F. Chronic effects of intratracheally instilled nickel-containing particles in hamsters. In: Nieboer E., and Nriagu J.O.E. (Eds). Nickel and Human Health: Current Perspective (1992), John Wiley & Sons, Inc. 467-479
43. NTP (National Toxicology Program), US Department of Health and Human Services, 1996a. National Toxicology Program Technical Report. Toxicological and carcinogenesis studies of nickel subsulfide in F344/N rats and B6C3F1 mice. NTP TR 453, NIH Publication Series No. 96-3369.
44. NTP (National Toxicology Program), US Department of Health and Human Services, 1996b. National Toxicology Program Technical Report. Toxicological and carcinogenesis studies of nickel oxide in F344/N rats and B6C3F1 mice. NTP TR 451, NIH Publication Series No. 96-3363.
45. NTP (National Toxicology Program), US Department of Health and Human Services, 1996c. National Toxicology Program Technical Report. Toxicological and carcinogenesis studies of nickel sulfate hexahydrate in F344/N rats and B6C3F1 mice. NTP TR 454, NIH Publication Series No. 96-3370.
46. Oller A.R., Costa M., and Oberdörster G. Carcinogenicity assessment of selected nickel compounds. Toxicol. Appl. Pharmacol. 143 (1997) 152-166
47. Ozaki K., Haseman J.K., Hailey J.R., Maronpot R.R., and Nyska A. Association of adrenal pheochromocytoma and lung pathology in inhalation studies with particulate compounds in the male F344 rat - the National Toxicology Program Experience. Toxicol. Pathol. 30 (2002) 263-270
48. Pang D., Burges D.C., and Sorahan T. Mortality study of nickel platers with special reference to cancers of the stomach and lung, 1945-93. Occup. Environ. Med. 53 (1996) 714-717
49. Peto R., Pike M.C., Day N.E., Gray R.G., Lee P.N., Parish S., Peto J., Richards S., and Wahrendorf J. Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. Long-Term and Short-Term Screening Assays for Carcinogenesis: a Critical Appraisal. IARC Monographs, Supplement 2 (1980), Lyon, France 311-426
50. Poteracki J., and Walsh K.W. Spontaneous neoplasms in control Wistar rats: a comparison of reviews. Toxicol. Sci. 45 (1998) 1-8
51. Pott F., Ziem U., Reiffer F.J., Huth F., Ernst H., and Mohr U. Carcinogenicity studies on fibers, metal compounds, and some other dusts in rats. Exp. Pathol. 32 (1987) 129-152
52. Salnikow K., and Kasprzak K.S. Ascorbate depletion: a critical step in nickel carcinogenesis?. Environ Health Perspect 113 5 (2005) 577-584
53. Salnikow K., Su W., Blagosklonny M.V., and Costa M. Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism. Cancer Res. 60 13 (2000) 3375-3378
54. Sivulka D.J. Assessment of respiratory carcinogenicity associated with exposure to metallic nickel: a review. Regul. Toxicol. Pharmacol. 43 (2005) 117-133
55. Snedecor G.W., and Cochran W.G. One way classifications; analysis of variance. Statistical Methods. 7th ed. (1980), The Iowa State University Press, Ames, IA 215-237
56. STP. Commentary. Documentation of the pathology peer review position of the Society of Toxicologic Pathologists. Toxicol. Pathol. 25 6 (1997) 655
57. Tsai P.J., Vincent J.H., Wahl G., and Maldonado G. Occupational exposure to inhalable aerosol in the primary nickel production industry. Occup. Environ. Med. 52 (1995) 793-799
58. Tsai P.J., Vincent J.H., Wahl G.A., and Maldonado G. Worker exposures to inhalable and 'total' aerosol during nickel alloy production. Ann. Occup. Hyg. 40 6 (1996) 651-659
59. Tsai P.J., Werner M.A., Vincent J.H., and Maldonado G. Worker exposure to nickel-containing aerosol in two electroplating shops: comparison between inhalable and total aerosol. Appl. Occup. Environ. Hyg. 11 5 (1996) 484-492
60. United States FDA. Guidance for industry: providing regulatory submissions in electronic Format - NDA's. U.S. Department of Health and Human Services, Center for Drug Evaluation and Research (CDER). IT3 (1999) 74 pages
61. Werner M.A., Thomassen Y., Hetland S., Norseth T., Berge S.R., and Vincent J.H. Correlation of urinary nickel excretion with observed 'total' and inhalable aerosol exposures of nickel refinery workers. J. Environ. Monit. 1 (1999) 557-562
62. Zar J.H. Multiple comparisons. Biostatistical Analysis. 4th ed. (1999), Prentice Hall, Upper Saddle River, NJ 208-214